[go: up one dir, main page]

AU2002350942A1 - Imidazolidineacetic acid derivatives - Google Patents

Imidazolidineacetic acid derivatives

Info

Publication number
AU2002350942A1
AU2002350942A1 AU2002350942A AU2002350942A AU2002350942A1 AU 2002350942 A1 AU2002350942 A1 AU 2002350942A1 AU 2002350942 A AU2002350942 A AU 2002350942A AU 2002350942 A AU2002350942 A AU 2002350942A AU 2002350942 A1 AU2002350942 A1 AU 2002350942A1
Authority
AU
Australia
Prior art keywords
acid derivatives
imidazolidineacetic acid
imidazolidineacetic
derivatives
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002350942A
Other versions
AU2002350942A8 (en
Inventor
Michael Bryan Roe
Andre Tartar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Ferring BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring BV filed Critical Ferring BV
Publication of AU2002350942A1 publication Critical patent/AU2002350942A1/en
Publication of AU2002350942A8 publication Critical patent/AU2002350942A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002350942A 2001-12-14 2002-12-12 Imidazolidineacetic acid derivatives Abandoned AU2002350942A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0129988.2 2001-12-14
GB0129988A GB0129988D0 (en) 2001-12-14 2001-12-14 Imidazolidineacetic acid derivatives
PCT/GB2002/005631 WO2003051848A2 (en) 2001-12-14 2002-12-12 Imidazolidineacetic acid derivatives

Publications (2)

Publication Number Publication Date
AU2002350942A1 true AU2002350942A1 (en) 2003-06-30
AU2002350942A8 AU2002350942A8 (en) 2003-06-30

Family

ID=9927662

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002350942A Abandoned AU2002350942A1 (en) 2001-12-14 2002-12-12 Imidazolidineacetic acid derivatives

Country Status (3)

Country Link
AU (1) AU2002350942A1 (en)
GB (1) GB0129988D0 (en)
WO (1) WO2003051848A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7550590B2 (en) 2003-03-25 2009-06-23 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
EP1625122A1 (en) 2003-05-14 2006-02-15 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
US20050070531A1 (en) 2003-08-13 2005-03-31 Syrrx, Inc. Dipeptidyl peptidase inhibitors
ATE553077T1 (en) 2004-07-23 2012-04-15 Nuada Llc PEPTIDATE INHIBITORS
MX2007011453A (en) 2005-04-22 2008-02-12 Alantos Pharmaceuticals Holding Inc Dipeptidyl peptidase-iv inhibitors.
US20070060530A1 (en) 2005-09-14 2007-03-15 Christopher Ronald J Administration of dipeptidyl peptidase inhibitors
EP1924567B1 (en) 2005-09-16 2012-08-22 Takeda Pharmaceutical Company Limited Process for the preparation of pyrimidinedione derivatives
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
CZ2008512A3 (en) 2008-08-26 2010-03-10 Zentiva, A. S Process for preparing extremely pure vildagliptin
CN104262227B (en) * 2014-09-16 2018-09-18 东北制药集团股份有限公司 A method of preparing (S) -1- (2- chloracetyls) pyrrolidines -2- formonitrile HCNs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW492957B (en) * 1996-11-07 2002-07-01 Novartis Ag N-substituted 2-cyanopyrrolidnes

Also Published As

Publication number Publication date
WO2003051848A3 (en) 2003-09-18
WO2003051848A2 (en) 2003-06-26
AU2002350942A8 (en) 2003-06-30
GB0129988D0 (en) 2002-02-06

Similar Documents

Publication Publication Date Title
AU2002349676A1 (en) 4-oxoquinoline derivatives
AU2002358718A1 (en) 2-heteroarylcarboxylic acid amides
AU2001280167A1 (en) Novel propenohydroxamic acid derivatives
AU2002347336A1 (en) Quinoline derivatives
AU2690600A (en) 2-mercaptocarboxylic acid derivatives
AU2002350942A1 (en) Imidazolidineacetic acid derivatives
AU2002347359A1 (en) Quinoline derivatives
AU2002321215A1 (en) Substituted 4-aminocyclohexanols
AU1303201A (en) Alkoxyiminoalkanoic acid derivatives
AU2002363600A1 (en) Novel phenyl-propargylether derivatives
AU2002235729A1 (en) Fusidic acid derivatives
AU2001293697A1 (en) N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
AU2002358715A1 (en) Tetrahydrobenzfluorene derivatives
AU2001228527A1 (en) Oxazolethoxyphenylpropanoic acid derivative as niddm- medicament
AU2002255269B8 (en) 2-Iminopyrrolidine derivatives
AU2001263853A1 (en) Alpha-sulfin- and alpha-sulfonamino acid amide derivatives
AU2001256759A1 (en) Sialic acid derivatives
AU2002244978A1 (en) Alpha-substituted omega-arylfatty acid derivative
AU2002355270A1 (en) Amino acid derivatives
HK1068131A (en) Amino acid derivatives
AU2002338875A1 (en) Acetic acid derivatives
AU2001276655A1 (en) Derivatives of para-ethoxy-phenillactic acid
AU2002302578A1 (en) Amido-diphenyl derivatives
AU2002325368A1 (en) Benzoylcyclohexenone derivatives
AU2002305184A1 (en) Cycloalkenylsulfonamide derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase